DOCSLIB.ORG

INFORMA PLC (Incorporated As a Public Limited Company in England and Wales)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
INFORMA PLC (Incorporated As a Public Limited Company in England and Wales) BASE LISTING PARTICULARS INFORMA PLC (incorporated as a public limited company in England and Wales) Guaranteed by certain other companies in the Enlarged Group £2,500,000,000 Euro Medium Term Note Programme Under the Euro Medium Term Note Programme described in this Base Listing Particulars (the "Base Listing Particulars") (the "Programme"), Informa PLC (the "Issuer"), subject to compliance with all relevant laws, regulations and directives, may from time to time issue euro medium term notes (the "Notes"). Application has been made to The Irish Stock Exchange plc trading as Euronext Dublin ("Euronext Dublin") for the Notes issued under the Programme during the period of twelve months from the date hereof to be admitted to the official list (the "Official List") and to trading on the Global Exchange Market of Euronext Dublin (the "GEM"). This offering circular has been approved by Euronext Dublin as a Base Listing Particulars. References in this Base Listing Particulars to Notes being "listed" (and all related references) shall mean that such Notes have been admitted to the Official List and to trading on the GEM. The Programme provides that Notes may be listed on such other or further stock exchange(s) as may be agreed between Issuer and the relevant Dealer (as defined below). This Base Listing Particulars does not constitute a prospectus for the purposes of Article 5 of Directive 2003/71/EC (as such directive may be amended from time to time, the "Prospectus Directive"). The Issuer is not offering the Notes in any jurisdiction in circumstances that would require a prospectus to be prepared pursuant to the Prospectus Directive. GEM is not a regulated market for the purposes of Directive 2014/65/EU (as amended, "MiFID II"). The Issuer has been assigned a rating of BBB by Standard & Poor's Credit Market Services Europe Limited ("S&P") and Baa3 by Moody's Investors Service Ltd ("Moody's"). S&P and Moody's are established in the European Economic Area ("EEA") and registered under Regulation (EC) No. 1060/2009, as amended (the "CRA Regulation"). Tranches of Notes to be issued under the Programme will be rated or unrated. Each of S&P and Moody's may in the future rate Notes issued under the Programme. Where a Tranche of Notes is to be rated, such rating will not necessarily be the same as the rating assigned to the Issuer. A security rating is not a recommendation to buy, sell or hold securities and may be subject to suspension, reduction or withdrawal at any time by the assigning rating agency. Investing in Notes issued under the Programme involves certain risks. The principal risk factors that may affect the abilities of the Issuer (as defined below) and the Guarantors (as defined below) to fulfil their respective obligations under the Notes are discussed under "Risk Factors" below. The Notes and the Guarantee of the Notes (as defined herein) have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "Securities Act") or with any securities regulatory authority of any state or other jurisdiction of the United States, and Notes in bearer form are subject to U.S. tax law requirements. The Notes may not be offered, sold or (in the case of Notes in bearer form) delivered within the United States or to, or for the account or benefit of, U.S. persons (as defined in Regulation S under the Securities Act ("Regulation S")) except in certain transactions exempt from the registration requirements of the Securities Act and in accordance with any applicable securities laws of any state or other jurisdiction of the United States. The Notes will only be offered and sold outside the United States to non-U.S. persons in reliance on Regulation S. ARRANGER BNP PARIBAS DEALERS BARCLAYS BNP PARIBAS BOFA MERRILL LYNCH MUFG SANTANDER 20 June 2018 224418-4-2-v19.4 70-40677637 CONTENTS Page IMPORTANT NOTICES ............................................................................................................................. 1 OVERVIEW ................................................................................................................................................. 6 RISK FACTORS ........................................................................................................................................ 10 INFORMATION INCORPORATED BY REFERENCE .......................................................................... 24 PRICING SUPPLEMENT AND DRAWDOWN LISTING PARTICULARS .......................................... 25 FORMS OF THE NOTES .......................................................................................................................... 26 TERMS AND CONDITIONS OF THE NOTES ....................................................................................... 32 FORM OF PRICING SUPPLEMENT ....................................................................................................... 66 USE OF PROCEEDS ................................................................................................................................. 74 INFORMATION ON THE ISSUER AND THE ENLARGED GROUP ................................................... 75 UNAUDITED PRO FORMA CONSOLIDATED FINANCIAL INFORMATION .................................. 88 DESCRIPTION OF THE INITIAL GUARANTORS ................................................................................ 95 TAXATION ............................................................................................................................................. 107 SUBSCRIPTION AND SALE ................................................................................................................. 111 GENERAL INFORMATION .................................................................................................................. 114 224418-4-2-v19.4 70-40677637 IMPORTANT NOTICES Responsibility for this Base Listing Particulars Each of Informa PLC ("Informa" or the "Issuer") and the Initial Guarantors (as defined below) accepts responsibility for the information contained in this Base Listing Particulars and the Pricing Supplement for each Tranche (as defined herein) of Notes issued under the Programme and declares that, having taken all reasonable care to ensure that such is the case, the information contained in this Base Listing Particulars is, to the best of its knowledge, in accordance with the facts and contains no omission likely to affect its import. Pricing Supplement/Drawdown Listing Particulars Each Tranche of Notes will be issued on the terms set out herein under "Terms and Conditions of the Notes" (the "Conditions") as completed to the extent described by a document specific to such Tranche called a pricing supplement (the "Pricing Supplement") or, as the case may be, as supplemented, amended and/or replaced to the extent described in a separate listing particulars specific to such Tranche (the "Drawdown Listing Particulars") as described under "Pricing Supplement and Drawdown Listing Particulars" below. Other relevant information This Base Listing Particulars must be read and construed together with any supplements hereto and with any information incorporated by reference herein and, in relation to any Tranche of Notes which is the subject of a Pricing Supplement, must be read and construed together with the relevant Pricing Supplement. In the case of a Tranche of Notes which is the subject of a Drawdown Listing Particulars, each reference in this Base Listing Particulars to information being specified or identified in the relevant Pricing Supplement shall be read and construed as a reference to such information being specified or identified in the relevant Drawdown Listing Particulars unless the context requires otherwise. The Issuer and the Initial Guarantors have confirmed to the Dealers named under "Subscription and Sale" below that this Base Listing Particulars contains all information which is (in the context of the Programme, the issue, offering and sale of the Notes (as defined below)) material; that such information is true and accurate in all material respects and is not misleading in any material respect; that any opinions, predictions or intentions expressed herein are honestly held or made and are not misleading in any material respect; that this Base Listing Particulars does not omit to state any material fact necessary to make such information, opinions, predictions or intentions (in the context of the Programme, the issue, offering and sale of the Notes) not misleading in any material respect; and that all proper enquiries have been made to verify the foregoing. Unauthorised information No person has been authorised by the Issuer or the Guarantors (as defined below) to give any information or to make any representation not contained in or not consistent with this Base Listing Particulars or any other document entered into in relation to the Programme or any information supplied by the Issuer or the Guarantors in relation to the Programme or the Notes, or such other information as is in the public domain and, if given or made, such information or representation should not be relied upon as having been authorised by the Issuer, the Guarantors, any Dealer or the Trustee. None of the Dealers, the Agents or the Trustee have separately verified the information contained in this Base Listing Particulars. None of the Dealers, the Agents or any of their respective affiliates have authorised the whole or any part of this Base Listing Particulars and none of them makes any representation
Load more

Recommended publications
  • Expect the Unexpected: Building Business Value in a Changing World
    Expect the Unexpected: Building business value in a changing world kpmg.com KPMG INTERNATIONAL PART 1 b | Expect the Unexpected: Building business value in a changing world In this report we offer a starting point for discussion. We present a system of ten sustainability megaforces that will impact each and every business over the next 20 years. We want to build awareness that these forces do not act alone in predictable ways. They are interconnected. They interact. Disclaimer: Throughout this document, "KPMG" ["we," "our," and "us"] refers to KPMG International, a Swiss entity that serves as a coordinating entity for a network of independent member firms operating under the KPMG name, KPMG's Climate Change and Sustainability practice, and/or to any one or more of such firms. KPMG International provides no client services. © 2012 KPMG International Cooperative (“KPMG International”), a Swiss entity. Member firms of the KPMG network of independent firms are affiliated with KPMG International. KPMG International provides no client services. All rights reserved. Expect the Unexpected: Building business value in a changing world | c Foreword usinesses today are operating in an ever more At KPMG’s network of firms we have always been at the interconnected and globalized world. Supply chains forefront of developments that shape business behavior. Bstretch across continents and are vulnerable to We are working with organizations to help them understand disruption. Consumer demands and government policies the forces at work that will influence markets and impact are changing rapidly and will impact your bottom line if your profitability in the medium to long term.
    [Show full text]
  • Genome Editing with CRISPR/Cas9 in Postnatal Mice Corrects PRKAG2 Cardiac Syndrome
    Cell Research (2016) 26:1099-1111. © 2016 IBCB, SIBS, CAS All rights reserved 1001-0602/16 $ 32.00 ORIGINAL ARTICLE www.nature.com/cr Genome editing with CRISPR/Cas9 in postnatal mice corrects PRKAG2 cardiac syndrome Chang Xie1, 2, *, Ya-Ping Zhang3, *, Lu Song2, *, Jie Luo1, Wei Qi2, Jialu Hu3, Danbo Lu3, Zhen Yang3, Jian Zhang2, Jian Xiao1, Bin Zhou4, Jiu-Lin Du5, Naihe Jing2, Yong Liu1, Yan Wang1, Bo-Liang Li2, Bao-Liang Song1, Yan Yan3 1Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Wuhan University, Wuhan 430072, China; 2The State Key Laboratory of Molecular Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yue-Yang Road, Shanghai 200031, China; 3Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai 200032, China; 4Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sci- ences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yue-Yang Road, Shanghai 200031, China; 5Institute of Neuroscience and State Key Laboratory of Neuroscience, Shanghai Institutes for Biological Sciences, Chinese Acade- my of Sciences, 320 Yue-Yang Road, Shanghai 200031, China PRKAG2 cardiac syndrome is an autosomal dominant inherited disease resulted from mutations in the PRK- AG2 gene that encodes γ2 regulatory subunit of AMP-activated protein kinase. Affected patients usually develop ventricular tachyarrhythmia and experience progressive heart failure that is refractory to medical treatment and requires cardiac transplantation. In this study, we identify a H530R mutation in PRKAG2 from patients with famil- ial Wolff-Parkinson-White syndrome. By generating H530R PRKAG2 transgenic and knock-in mice, we show that both models recapitulate human symptoms including cardiac hypertrophy and glycogen storage, confirming that the H530R mutation is causally related to PRKAG2 cardiac syndrome.
    [Show full text]
  • 2015 Informa Investor Day
    2015 Informa Investor Day 18 November 2015 INTRODUCTION STEPHEN A. CARTER GROUP CHIEF EXECUTIVE 2015 Informa Investor Day Presentation Schedule • Introduction • Academic Publishing – Content Depth and Operating Efficiency • Global Exhibitions – Maximising the Growth Opportunity • Greenbuild – Overview & Tour • Lunch • Operational & Financial Update • Summary and Q&A THE JOURNEY SO FAR Stephen Carter appointed 2014 Investor Day Group CEO & launch of Disposal of Consumer Info. strategic review Review of strategic options for European Conferences Gareth Wright confirmed as Group FD, external appointment of BI and K&N Dwell acquisition FIME acquisition CEO’s 2013 2016 2014-2017 Growth Hanley Wood Disposal of Acceleration Plan Exhibitions acquisition Scandinavian announced and placing Conferences New operating Virgo acquisition Orlando Megacon Disposal of Dutch structure announced acquisition Conferences INFORMA GROUP INVESTOR DAY NOVEMBER 2015 4 2014-2017 GROWTH ACCELERATION PLAN FRAMEWORK Growth Acceleration Plan GAP GAP GAP GAP GAP GAP Operating Management Portfolio Acquisition Investment Funding Structure Model Management Strategy • 4 Operating Divisions • EMT established • Consumer Info disposal • Hanley Wood Exhib. • £70-90m programme • Renegotiated RCF • Global Support • Divisional SMTs • InsuranceIQ disposal • Virgo • 30-40 projects • $250m PPP issue • Medical Journals transfer • GE succession • Chinese Pharma closure • Orlando Megacon • 21 projects underway • Group Treasurer • WPA and Learning transfer • 3 yr business plans • Closure
    [Show full text]
  • Novartis Swaps Two Avexis Executives for One Following
    No. 3969 August 23, 2019 and CSO that the Kaspars have not been involved in the Novartis subsidiary’s op- erations since early May. Asked whether more AveXis employees will exit the company due to the preclini- cal safety data manipulation revealed on 6 August or whether other actions will be taken by Novartis in relation to the matter, Althoff told Scrip: “We cannot comment on the specifics of who is involved, but we can confirm this issue was not widespread, ei- ther in our overall dataset nor in our com- pany or any function within our company and was limited to a few individuals.” Novartis CEO Vas Narasimhan said in a 7 August conference call about the Zol- gensma data controversy that the compa- ny was in the process of “exiting the small number of AveXis scientists involved” in the data manipulation, which occurred Novartis Swaps Two AveXis before Novartis bought the gene therapy firm. (Also see “Novartis CEO Explains De- lay In Telling US FDA About Zolgensma Executives For One Following Data Fraud: We Wanted To Understand It First” - Pink Sheet, 7 Aug, 2019.) Zolgensma Data Manipulation Novartis acquired AveXis for $8.7bn MANDY JACKSON [email protected] last year. (Also see “Novartis Goes Big On Gene Therapy With $8.7bn AveXis Acquisi- ovartis AG said when it disclosed the Zolgensma BLA was manipulated. Page tion” - Scrip, 9 Apr, 2018.) Zolgensma was that preclinical safety data for Zol- Bouchard, whose most recent function was the lead asset in AveXis’s R&D pipeline and Ngensma were manipulated in the bi- global head of preclinical safety for Novar- won US Food and Drug Administration ologic license application for the gene ther- tis Institutes of Biomedical Research (NIBR), approval in May, becoming the world’s apy that the company would be “exiting” was named senior vice president and chief most expensive drug with a $2m list price.
    [Show full text]
  • 2.7 Informa Recommended Offer for UBM.Pdf
    THIS ANNOUNCEMENT IS AN ADVERTISEMENT AND NOT A PROSPECTUS OR PROSPECTUS EQUIVALENT DOCUMENT AND INVESTORS SHOULD NOT MAKE ANY INVESTMENT DECISION IN RELATION TO THE NEW INFORMA SHARES EXCEPT ON THE BASIS OF INFORMATION IN THE PROSPECTUS AND THE SCHEME DOCUMENT WHICH ARE PROPOSED TO BE PUBLISHED IN DUE COURSE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR IMMEDIATE RELEASE 30 January 2018 CREATION OF A LEADING B2B INFORMATION SERVICES GROUP THROUGH A RECOMMENDED OFFER FOR UBM PLC BY INFORMA PLC The boards of Informa PLC ("Informa") and UBM plc ("UBM") are pleased to confirm the creation of a leading B2B Information Services Group (the "Enlarged Group") through a recommended offer (the "Offer") for UBM by Informa. The Offer, which is being recommended to shareholders by the boards of Informa and UBM, comprises a mix of shares and cash consideration from Informa for the entire issued and to be issued share capital of UBM. The boards of both companies believe there is a compelling commercial and strategic rationale for creating the Enlarged Group, to offer major benefits to Customers and Colleagues, while having the potential to create significant value for Shareholders, supported by accelerated growth opportunities, significant operating synergies and attractive earnings accretion. Stephen A. Carter, Chief Executive of Informa said: "It is clear that the B2B Market is moving to Operating Scale and Industry Specialisation. Our recommended offer for UBM promises to create a leading B2B Information Services Group with the international reach and market capabilities to take full advantage of these trends." He added: "The Enlarged Group has the potential to deliver strong growth and significant value for shareholders.
    [Show full text]
  • Ascential Secure
    Ascential Secure Enhanced Health & Safety Standards at Ascential’s Events in a Post-COVID-19 World 1 ​ About Ascential Secure Ascential Secure is our approach to enhanced health and safety standards at our events following COVID-19. From exhibitors to sponsors, speakers, visitors and journalists, those who come to our events do so to gain the information, insights, connections, data and digital tools that they need, effectively and safely. The standards and practices that make up Ascential Secure are designed to provide confidence that at every Ascential event, we are striving to provide the highest standards of safety, hygiene, cleanliness and quality. Whether they are exhibitors, attendees, visitors, speakers or sponsors, people come to events to connect, learn, know more and do more business, effectively, safely and with confidence. Ascential Secure is based on a set of event industry standards, called AllSecure. The AllSecure industry standards were developed collaboratively by a group including industry associations UFI, AEO and SISO, event organisers Informa, Reed Exhibitions and Clarion, a range of event venues, suppliers and with input from health, government and local authorities. Ascential Secure is the way these industry-wide AllSecure standards are being applied to Ascential live events. You can expect to see that health and safety continues to be a priority, and that a range of measures are in place to ensure everyone involved is able to enjoy a safe, hygienic, productive and high-quality organised event experience. As a starting point, Ascential Secure events will be run according to the guidance of the government or official local authority for that location, and according to any venue-specific regulations.
    [Show full text]
  • Annual Report 2017 Talktalk Telecom Group PLC Talktalk Is the UK’S Leading Value for Money Connectivity Provider
    TalkTalk Telecom Group PLC Group Telecom TalkTalk Annual Report2017 2017 Annual Report 2017 TalkTalk Telecom Group PLC TalkTalk is the UK’s leading value for money connectivity provider� Our mission is to deliver simple, affordable, reliable and fair connectivity for everyone� Stay up to date at talktalkgroup.com Contents Strategic report Corporate governance Financial statements Highlights ������������������������������������������������������������������������ 01 Board of Directors and PLC Committee ������������� 32 Independent auditor’s report �������������������������������� 66 At a glance ���������������������������������������������������������������������� 02 Corporate governance ���������������������������������������������� 36 Consolidated income statement �������������������������� 73 Chairman’s introduction ������������������������������������������ 04 Audit Committee report ������������������������������������������� 41 Consolidated statement of comprehensive FY17 business review ������������������������������������������������� 05 Directors’ remuneration report ����������������������������� 44 income ���������������������������������������������������������������������������� 74 Business model and strategy ��������������������������������� 08 Directors’ report ���������������������������������������������������������� 63 Consolidated balance sheet ����������������������������������� 75 Measuring our performance ����������������������������������� 12 Directors’ responsibility statement ��������������������� 65 Consolidated
    [Show full text]
  • Annual Report 2020
    In pursuit of progress since Annual report 2020 report Annual Annual report 2020 In pursuit of progress since Annual report 2020 report Annual Annual report 2020 CONTENTS ANNUAL REPORT STRATEGIC REPORT 2 Five-year summary 3 Group overview 4 From the chairman 6 From the chief executive 8 From the editor 9 Business review: the year in detail 13 The Economist Educational Foundation 15 The Economist Group and environmental sustainability 17 Corporate governance: the Wates Principles, our Section 172(1) statement and our guiding principles REPORT AND ACCOUNTS GOVERNANCE 22 Directors 23 Executive team 24 Trustees, board committees 25 Directors’ report 28 Directors’ report on remuneration 31 Financial review CONSOLIDATED FINANCIAL STATEMENTS 35 Independent auditor’s report to the members of The Economist Newspaper Limited 38 Consolidated income statement 39 Consolidated statement of comprehensive income 40 Consolidated balance sheet 41 Consolidated statement of changes in equity 42 Consolidated cashflow statement 44 Notes to the consolidated financial statements COMPANY FINANCIAL STATEMENTS 94 Company balance sheet 95 Company statement of changes in equity 96 Notes to the company financial statements NOTICES 108 Notice of annual general meeting 1 STRATEGIC REPORT Five-year summary 2020 2019 2018 2017 2016 £m £m £m £m £m Income statement—continuing business* Revenue 326 333 329 303 282 Operating profit 31 31 38 43 47 Profit after taxation 21 25 28 39 37 Profit on sale of CQ-Roll Call, Inc - 43 - - - Profit on sale of Economist Complex - - - -
    [Show full text]
  • Informa PLC Interim Results for Six Months to 30 June 2016 Continued Operational and Financial Progress in Peak Year of GAP Investment
    Press Release 28 July 2016 Informa PLC Interim Results for Six Months to 30 June 2016 Continued Operational and Financial Progress in Peak Year of GAP investment KEY FINANCIAL HIGHLIGHTS Accelerating organic revenue growth: +2.5% vs +0.2% in H1 2015 and +1.0% FY 2015 Higher reported revenue: +4.7% to £647.7m (H1 2015: £618.8m) Increased adjusted operating profit: +6.3% to £202.2m (H1 2015: £190.3m) Higher statutory operating profit: +8.6% to £141.6m (H1 2015: £130.4m*) Growth in adjusted diluted EPS: +3.1% to 23.1p (H1 2015: 22.4p*) Increased interim dividend: up 4% to 6.80p (H1 2015: 6.55p) Robust balance sheet with secure pension position: Gearing of 2.4x (H1 2015: 2.4x) Strong underlying free cash flow, full year on track; first-half phasing with £20m GAP investment: £67.7m (H1 2015: £116.4m) London: Informa (LSE: INF.L), the international Business Intelligence, Exhibitions, Events and Academic Publishing Group, today reported solid growth in Revenue, Operating Profit and Earnings Per Share for the six months to 30 June 2016 in the peak investment year of the 2014-2017 Growth Acceleration Plan (“GAP”). Operational and Financial Momentum in peak year of GAP Investment – robust trading and improving earnings visibility in all four Operating Divisions: o Global Exhibitions…Growing: Benefits of high quality Brand portfolio, scale and US expansion delivering continued double-digit growth; o Academic Publishing…Resilient: Simplified operating structure, focus on Upper Level Academic Market and further investment in specialist content
    [Show full text]
  • Beijing Hits Back After US Treasury Labels China a Currency Manipulator
    BUSINESS WITH PERSONALITY HEARTBREAK BLAST FROM THE PAST HOTEL WHEN A NEW SUPERCHARGED HOLIDAYS GO £90K CLASSIC MINI P18 WRONG P17 WEDNESDAY 7 AUGUST 2019 ISSUE 3,430 CITYAM.COM FREE CRYIN’ KING Disney investors GOVE POINTS tearful despite box office success THE FINGER CATHERINEAT NEILAN BRUSSELSthe backing of the Commons. ratification of the withdrawal agree- “We can’t have a deal that doesn’t ment, or further extension or revoca- @CatNeilan command the confidence of the gov- tion of Article 50... [I am] certainly not THE UK has accused the EU of refusing ernment, the parliament and the fatalistic about that. to budge on Brexit negotiations and in- country and that is why we have been “Our position is that the withdrawal sisted the bloc “must change its clear with the European Union that agreement, including the backstop is stance” if a no-deal exit is to be dodged. we need a new approach,” he closed, but there is always room for Ireland’s Leo Varadkar yesterday responded. talks and negotiations. We have said said he was confident a no-deal Brexit “We stand ready to engage with the we can certainly make changes to the could still be avoided, despite EU to negotiate in good faith… political declaration, and we have Prime Minister Boris Johnson We will put all our energy demonstrated before to offer clarifica- stressing the UK will leave into making sure we can tions as we did at the request of Prime the European Union “do secure that good deal. Minister May in the past.” or die”, come 31 Octo- “At the moment it’s Yesterday the pound hit its lowest ber.
    [Show full text]
  • Introduction to Ascential Our Investment Case
    INTRODUCTION TO ASCENTIAL OUR INVESTMENT CASE Clear long-term vision. Helping leading global brands connect with their customers in a data-driven world. Structural growth. Demand for information, data & analytics driven by growth of digital commerce. Market leaders. We are leaders, with a unique blend of specialisms, in the high growth areas in which we operate. Robust business model. High recurring and repeat revenue, with more than 50% revenues from digital subscription and platforms, across diverse global customer base. Attractive financial profile. Track record of high single digit revenue growth, strong margins and cash generation, supported by sound capital allocation. Introduction to Ascential 2 OUR CUSTOMER PROPOSITION Our information products and platforms support our customers to do three simple things… CREATE THE RIGHT MAXIMISE THE OPTIMISE DIGITAL PRODUCTS BRAND MARKETING COMMERCE IMPACT Know which products Know how to get Know how to execute the consumer wants maximum creativity with with excellence on the tomorrow. optimised media. winning platforms. 1. 2. 3. Introduction to Ascential 3 SEGMENTAL OVERVIEW –2019 Segment Revenue % Revenue1 Growth1 EBITDA2 Margin Business Model Advisory 10% Digital Subscriptions Product £86m 21% +8% £36m 42% & Platforms 90% Design Digital Subscriptions Advisory & Platforms 11% Marketing £136m 32% +9% £51m 37% 37% Events 52% Advisory 6% Digital Subscriptions & Sales - Platforms 94% Digital £90m 22% +21% £13m 15% Commerce Sales - Digital Subscriptions & Events Platforms 4% Non Digital £68m 16%
    [Show full text]
  • VOLUME II Public School Code of 1949 Goods and Services Expenditures Fiscal Year 2017-2018
    Public School Code of 1949 Goods and Services Expenditures Fiscal Year 2017-2018 VOLUME II Temple University Financial Disclosure Report Purchase of Goods and Services Contracts Notes and Definitions The following report provides the required disclosures for reporting the purchase of goods and services contracts. The University’s Banner Finance System does not include data enabling the distinction between the purchases of goods and services. Therefore, a single report is provided that includes both. Expenditures are categorized in the attached report using the following categories: General Supplies & Services: o General supplies, expendable equipment and software. Health Service Programs: o Animal lab, professional billing and other outside professional services. Insurance: o Malpractice, property, general liability, and employees insurances. Interest & Taxes: o Bond interest, real estate tax and debt service costs. Library: o Books, electronic periodicals, subscriptions and film. Professional Fees & Contracts: o Auditing, legal and collection fees and subcontracts. Property, Plant & Equipment: o Capital equipment, buildings and building improvements. Rent: o Equipment, building and office rentals. Repairs & Maintenance: o Equipment repair, maintenance of buildings and grounds. Telecommunications: o Telephone equipment, data communications and cellular services. Travel: o Travel agency fees, foreign and domestic travel expenses. Utilities: o Electric, gas, water, sewer, steam, chilled water and other miscellaneous utilities expenses. Each entry provides the category into which the purchase falls, the vendor name and address and the amount of the purchase. There is no more than one entry per vendor for a single category within a responsibility center. Purchases of goods and services in the Disclosure Report include those which equal or exceed $1,000 for each vendor from all Budgeted Operating Funds including Temple University Physicians.
    [Show full text]